Symbol="IPHA"
AssetType="Common Stock"
Name="Innate Pharma"
Description="Innate Pharma SA, a biotechnology company, discovers, develops and markets therapeutic antibodies for the treatment of oncological indications in France and internationally. The company is headquartered in Marseille, France."
CIK="1598599"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="117 AVENUE DE LUMINY, BP 30191, MARSEILLE, FR"
FiscalYearEnd="December"
LatestQuarter="2022-06-30"
MarketCapitalization="259318000"
EBITDA="-12020000"
PERatio="None"
PEGRatio="None"
BookValue="0.675"
DividendPerShare="0"
DividendYield="0"
EPS="-0.75"
RevenuePerShareTTM="0.724"
ProfitMargin="-1.007"
OperatingMarginTTM="-0.285"
ReturnOnAssetsTTM="-0.0432"
ReturnOnEquityTTM="-0.718"
RevenueTTM="57674000"
GrossProfitTTM="57674000"
DilutedEPSTTM="-0.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.061"
AnalystTargetPrice="8.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.097"
PriceToBookRatio="1.345"
EVToRevenue="2.026"
EVToEBITDA="-5.43"
Beta="0.266"
num_52WeekHigh="3.97"
num_52WeekLow="1.9"
num_50DayMovingAverage="3.041"
num_200DayMovingAverage="2.826"
SharesOutstanding="80464000"
DividendDate="None"
ExDividendDate="None"
symbol="IPHA"
open="3.01"
high="3.12"
low="2.98"
price="3.12"
volume="1698.00"
latest_trading_day="2023-07-07"
previous_close="2.94"
change="0.18"
change_percent="6.1224%"
aroon_positive_momentum_days="68"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="16618"
Change_recent_avg="-0.01"
Delta_recent_avg="0.17"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_negative_thumbnail_id_2="156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0020.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="617"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0091.jpeg"
image_positive_thumbnail_id_2="984"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
